These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
504 related items for PubMed ID: 18286426
21. Intravenous infusion of bone marrow mesenchymal stem cells improves myocardial function in a rat model of myocardial ischemia. Wang T, Tang W, Sun S, Ristagno G, Huang Z, Weil MH. Crit Care Med; 2007 Nov; 35(11):2587-93. PubMed ID: 17828039 [Abstract] [Full Text] [Related]
25. Bone marrow-derived mesenchymal stromal cells express cardiac-specific markers, retain the stromal phenotype, and do not become functional cardiomyocytes in vitro. Rose RA, Jiang H, Wang X, Helke S, Tsoporis JN, Gong N, Keating SC, Parker TG, Backx PH, Keating A. Stem Cells; 2008 Nov; 26(11):2884-92. PubMed ID: 18687994 [Abstract] [Full Text] [Related]
26. Improved outcomes of cardiopulmonary resuscitation in rats with myocardial infarction treated with allogenic bone marrow mesenchymal stem cells. Wang T, Tang W, Sun S, Ristagno G, Xu T, Weil MH. Crit Care Med; 2009 Mar; 37(3):833-9. PubMed ID: 19237885 [Abstract] [Full Text] [Related]
27. Intravenous transplantation of mesenchymal stem cells improves cardiac performance after acute myocardial ischemia in female rats. Jiang W, Ma A, Wang T, Han K, Liu Y, Zhang Y, Zhao X, Dong A, Du Y, Huang X, Wang J, Lei X, Zheng X. Transpl Int; 2006 Jul; 19(7):570-80. PubMed ID: 16764636 [Abstract] [Full Text] [Related]
28. TNFR gene-modified mesenchymal stem cells attenuate inflammation and cardiac dysfunction following MI. Bao C, Guo J, Lin G, Hu M, Hu Z. Scand Cardiovasc J; 2008 Feb; 42(1):56-62. PubMed ID: 17852784 [Abstract] [Full Text] [Related]
29. Mesenchymal stem cells and their potential as cardiac therapeutics. Pittenger MF, Martin BJ. Circ Res; 2004 Jul 09; 95(1):9-20. PubMed ID: 15242981 [Abstract] [Full Text] [Related]
32. Emerging role for bone marrow derived mesenchymal stem cells in myocardial regenerative therapy. Zimmet JM, Hare JM. Basic Res Cardiol; 2005 Nov 09; 100(6):471-81. PubMed ID: 16237508 [Abstract] [Full Text] [Related]
35. Time course of myocardial stromal cell-derived factor 1 expression and beneficial effects of intravenously administered bone marrow stem cells in rats with experimental myocardial infarction. Ma J, Ge J, Zhang S, Sun A, Shen J, Chen L, Wang K, Zou Y. Basic Res Cardiol; 2005 May 09; 100(3):217-23. PubMed ID: 15754085 [Abstract] [Full Text] [Related]
39. Effects of autologous stem cells on immunohistochemical patterns and gene expression of metalloproteinases and their tissue inhibitors in doxorubicin cardiomyopathy in a rabbit model. Aupperle H, Garbade J, Schubert A, Barten M, Dhein S, Schoon HA, Mohr FW. Vet Pathol; 2007 Jul 09; 44(4):494-503. PubMed ID: 17609194 [Abstract] [Full Text] [Related]
40. Neovascularization and cardiomyocytes regeneration in acute myocardial infarction after bone marrow stromal cell transplantation: comparison of infarct-relative and noninfarct-relative arterial approaches in swine. Yang ZJ, Ma DC, Wang W, Xu SL, Zhang YQ, Chen B, Zhou F, Zhu TB, Wang LS, Jia EZ, Zhang FM, Cao KJ, Xu ZQ, Ma WZ. Clin Chim Acta; 2007 Jun 09; 381(2):114-8. PubMed ID: 17400203 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]